bpc-157 is overrated The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and Safety Should YOU Be Taking BPC-157
Description
Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin
The gastrointestinal tract stem cell niche
These findings have stimulated clinical development attempts, particularly for NAD + modulators deemed suitable for human trials in terms of safety and upscaling, such as natural precursors
Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial
Microneedling, mesotherapy-style injections, tattoo-assisted delivery and post-transplant scalp protocols make it easier to place active compounds closer to the follicle
